Our Custom Research services
In addition to our comprehensive ADME-Tox service portfolio, we perform various different quantitative and qualitative custom analyses, and can set up ad hoc experiments to address specific research questions to support our customers. Importantly, a wide range of services are available within the Symeres organization, such as integrated drug discovery.
If you don’t see the assay you are looking for, we would welcome the opportunity to discuss how we can help you. Contact us here.
Frequently Asked Questions
Custom ADME-Tox studies may be valuable when a standard assay does not fully address the scientific question, compound characteristics, analytical requirements, or development challenge of a project. Admescope can work with clients to design studies that generate the specific data needed to support decision-making.
Admescope performs a variety of custom quantitative and qualitative analyses, as well as ad hoc experiments designed to address specific research questions. Custom studies can support ADME-Tox, DMPK, bioanalysis, drug metabolism, and broader drug discovery activities.
Yes. If you do not see the assay you are looking for within the standard service portfolio, Admescope welcomes the opportunity to discuss your requirements and explore whether a suitable custom approach can be developed.
Admescope can discuss custom experimental approaches and ad hoc studies designed to address specific research questions. Depending on project requirements, custom work may involve quantitative analysis, qualitative analysis, drug metabolism investigations, bioanalysis, DMPK studies, or other ADME-Tox-related activities.
Yes. Custom services can be designed around the specific objectives of a project, including the research question, compound properties, analytical requirements, and stage of drug discovery or development.
Yes. Admescope performs both quantitative and qualitative analyses to help answer project-specific questions and support decision-making across ADME-Tox, DMPK, bioanalysis, and drug metabolism research.
Yes. As part of Symeres, Admescope can support projects that require expertise beyond ADME-Tox. Clients may also benefit from access to wider capabilities across the organization, including integrated drug discovery services where appropriate.
